[Our experience using triderm for the treatment of external otitis].
Vakhrushev
S G
SG
Pronina
Iu V
IuV
Zyrianov
M M
MM
Bugakova
T M
TM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001230:Aspergillus / Q000302:isolation & purification; D001419:Bacteria / Q000302:isolation & purification; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002175:Candida / Q000302:isolation & purification; D003022:Clotrimazole / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010032:Otitis Externa / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D004338:Drug Combinations; D005839:Gentamicins; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D003022:Clotrimazole